Comment from PubMed Commons 19 Jul 2015 Miguel Lopez-Lazaro | Jul 12 2015 07:25 ESTThe authors discuss that their results provide preclinical evidence proposing the use of SYK inhibitors in combination with paclitaxel in cancer patients…